BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3350995)

  • 1. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
    Shearer MJ; Bechtold H; Andrassy K; Koderisch J; McCarthy PT; Trenk D; Jähnchen E; Ritz E
    J Clin Pharmacol; 1988 Jan; 28(1):88-95. PubMed ID: 3350995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
    Schäfer H; Naber K; Adam D
    Arzneimittelforschung; 1989 Sep; 39(9):1156-62. PubMed ID: 2590268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of cefoxitin and cefotetan on vitamin K metabolism.
    Sieradzan RR; Bottner WA; Fasco MJ; Bertino JS
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1446-9. PubMed ID: 3196007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of cefixime on the metabolism of vitamin K1.
    Trenk D; Wagner F; Bechtold H; Nies B; Jähnchen E
    J Clin Pharmacol; 1990 Aug; 30(8):737-42. PubMed ID: 2401753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.
    Mackie IJ; Walshe K; Cohen H; McCarthy P; Shearer M; Scott SD; Karran SJ; Machin SJ
    J Clin Pathol; 1986 Nov; 39(11):1245-9. PubMed ID: 3466904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoprothrombinemia associated with cefmetazole.
    Breen GA; St Peter WL
    Ann Pharmacother; 1997 Feb; 31(2):180-4. PubMed ID: 9034420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.
    Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible coumarin-like mechanism of action for cephalosporins.
    Bechtold H; Lorenz J; Weilemann LS; Meinertz T; Trenk D; Andrassy K; Jähnchen E
    Klin Wochenschr; 1984 Sep; 62(18):885-6. PubMed ID: 6492697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?
    Agnelli G; Del Favero A; Parise P; Guerciolini R; Pasticci B; Nenci GG; Ofosu F
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1108-9. PubMed ID: 3729364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of antibiotic-associated hypoprothrombinemia.
    Schentag JJ; Welage LS; Grasela TH; Adelman MH
    Pharmacotherapy; 1987; 7(3):80-6. PubMed ID: 3306622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired hemostasis caused by beta-lactam antibiotics.
    Sattler FR; Weitekamp MR; Sayegh A; Ballard JO
    Am J Surg; 1988 May; 155(5A):30-9. PubMed ID: 3287966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins.
    Bechtold H; Andrassy K; Jähnchen E; Koderisch J; Koderisch H; Weilemann LS; Sonntag HG; Ritz E
    Thromb Haemost; 1984 Jul; 51(3):358-61. PubMed ID: 6548584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K1 levels.
    Cohen H; Scott SD; Mackie IJ; Shearer M; Bax R; Karran SJ; Machin SJ
    Br J Haematol; 1988 Jan; 68(1):63-6. PubMed ID: 3422816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers.
    Allison PM; Mummah-Schendel LL; Kindberg CG; Harms CS; Bang NU; Suttie JW
    J Lab Clin Med; 1987 Aug; 110(2):180-8. PubMed ID: 3598347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate.
    Bovill EG; Soll RF; Lynch M; Bhushan F; Landesman M; Freije M; Church W; McAuliffe T; Davidson K; Sadowski J
    Blood; 1993 Jan; 81(1):77-83. PubMed ID: 8417804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K reversible hypoprothrombinemia in rats. II. Efficacy of vitamin K on latamoxef-induced coagulopathy in rats.
    Matsuura M; Satoh S; Kobayashi F; Matsubara T; Uchida K
    Jpn J Pharmacol; 1988 Aug; 47(4):357-65. PubMed ID: 3184567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces.
    Nakamura K; Toyohira H; Kariyazono H; Ishibashi M; Saigenji H; Shimokawa S; Taira A
    Artery; 1994; 21(3):148-60. PubMed ID: 7794122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.
    Choonara IA; Scott AK; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1985 Dec; 20(6):643-8. PubMed ID: 4091996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.